Triglyceride-Glucose–Related Indexes as Risk Factors for Vision-Threatening Ocular Diseases: A Prospective UK Biobank Study
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.10.48 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Zhiqian Huang and 6 co-authors. Institution: Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China. Major MEDLINE topics: Triglycerides, Blood Glucose, Diabetic Retinopathy, Cataract. 93 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
To evaluate the associations of the triglyceride-glucose (TyG) index and related obesity-combined indexes with the incidence of major vision-threatening ocular diseases.
Methods
This prospective population-based cohort study included 400,237 participants from the UK Biobank. The TyG index and derived indexes (combined with waist circumference, waist-to-height ratio, and body mass index) were calculated using baseline laboratory and anthropometric data. The outcomes were incident cases of cataract, POAG, AMD, and diabetic retinopathy (DR), ascertained using self-reported data, hospital inpatient records, and primary care records. Cox proportional hazards models were used, with restricted cubic splines fitted to characterize dose-response relationships. Secondary analyses assessed the associations with retinal thicknesses and vascular features.
Results
Over a median follow-up of 13.0 years, 46,151 cataract, 6317 POAG, 8276 AMD, and 5220 DR incident cases were identified. Distinct nonlinear associations were observed: the TyG index exhibited a reverse L-shaped relationship with cataract and DR, a J-shaped association with AMD, and a U-shaped relationship with POAG (all P total < 0.01, all P nonlinear < 0.05), suggesting an estimated optimal range from 8.6 to 9.1. Furthermore, elevated TyG-obesity indexes exhibited monotonic positive associations with the risk of cataract, AMD, and DR (all P total < 0.001), whereas moderate elevation was associated with a reduced risk of POAG (all P total < 0.01, all P nonlinear < 0.05). Elevated TyG-obesity indexes were also associated with retinal thinning and vascular abnormalities, providing supportive discrimination and risk-stratification information for incident DR.
Conclusions
The TyG index and related obesity-combined indexes show disease-specific associations with major sight-threatening conditions, accompanied by retinal structural alterations. Maintaining these parameters within optimal ranges could help mitigate the risk of vision impairment.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
- NHC Key laboratory of Myopia and Related Eye Diseases; Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, China.
- Key Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, China.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
Cite
APA
Huang, Z., Jian, L., Xiang, J., Du, Y., Liu, S., Lu, Y., & Zhu, X. (2026). Triglyceride-Glucose–Related Indexes as Risk Factors for Vision-Threatening Ocular Diseases: A Prospective UK Biobank Study. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.10.48
Vancouver
Huang Z, Jian L, Xiang J, Du Y, Liu S, Lu Y, et al. Triglyceride-Glucose–Related Indexes as Risk Factors for Vision-Threatening Ocular Diseases: A Prospective UK Biobank Study. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.10.48
BibTeX
@article{Huang2026,
author = {Huang, Zhiqian and Jian, Linge and Xiang, Jing and Du, Yu and Liu, Shuyu and Lu, Yi and Zhu, Xiangjia},
title = {Triglyceride-Glucose–Related Indexes as Risk Factors for Vision-Threatening Ocular Diseases: A Prospective UK Biobank Study},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.10.48}
}
EUVIMED